← Back to guidelines
Dentistry5 papers

Vesicular pharyngitis

Last edited:

Overview

Vesicular pharyngitis, often referred to as herpetiform or herpangina-like conditions, presents a diagnostic challenge due to its varied etiology and overlapping clinical features with other infectious processes. While viral causes such as Coxsackievirus and Enterovirus are commonly implicated, recent evidence suggests that fungal infections, particularly Candida species, may also play a significant role in certain cases, especially in vulnerable populations like neonates. This guideline aims to provide clinicians with a comprehensive understanding of the pathophysiology, differential diagnosis, diagnostic approach, and management strategies for vesicular pharyngitis, emphasizing the importance of considering fungal etiologies in the differential diagnosis.

Pathophysiology

The pathophysiology of vesicular pharyngitis is multifaceted, often involving viral mechanisms that lead to localized inflammation and vesicle formation. Typically, viral pathogens such as Coxsackievirus A and Enterovirus 71 initiate infection through mucosal surfaces, triggering an immune response characterized by vesicular eruptions. However, recent studies highlight the potential involvement of fungal pathogens, particularly Candida species, in the development of vesicular pharyngitis, especially in immunocompromised or extremely premature neonates [PMID:36813738]. In these cases, Candida infections can manifest with diffuse, erythematous skin eruptions that may extend to involve the pharyngeal mucosa, leading to symptoms that overlap with viral vesicular pharyngitis. The exact mechanisms by which Candida induces vesicular lesions are not fully elucidated but likely involve direct tissue invasion and immune-mediated responses, underscoring the need for a broad differential diagnosis that includes fungal etiologies.

Differential Diagnosis

The differential diagnosis for vesicular pharyngitis is broad and includes both viral and fungal pathogens, as well as other infectious and non-infectious causes. Common viral etiologies include Coxsackievirus A, Enterovirus 71, and Herpes Simplex Virus (HSV), each presenting with characteristic vesicular lesions and systemic symptoms. However, the clinical presentation can be ambiguous, particularly in neonates and immunocompromised individuals. A notable case series involving two extremely premature neonates with Candida septicemia illustrates the critical importance of considering fungal infections in the differential diagnosis [PMID:36813738]. These neonates presented with diffuse, erythematous skin eruptions that healed with reticulated and supple scarring, mimicking vesicular pharyngitis. This clinical scenario emphasizes that fungal infections, especially Candida, should not be overlooked, as they can present with similar vesicular or erythematous lesions, complicating the diagnostic process. Other differential considerations include allergic reactions, chemical irritants, and autoimmune conditions, necessitating a thorough clinical evaluation and targeted diagnostic testing to rule out these possibilities.

Diagnosis

Diagnosing vesicular pharyngitis requires a systematic approach that combines clinical assessment with laboratory and imaging modalities tailored to the suspected etiology. Clinical evaluation should focus on the characteristic vesicular lesions, their distribution, and associated symptoms such as fever, sore throat, and difficulty swallowing. In neonates and immunocompromised patients, where fungal infections like Candida are more likely, a high index of suspicion is crucial. Diagnostic confirmation often involves multiple steps:

  • Clinical Samples: Throat swabs and vesicular fluid should be collected for viral culture and PCR testing to identify common viral pathogens such as Coxsackievirus and Enterovirus. For suspected fungal infections, these samples should also be subjected to fungal cultures and antigen detection tests.
  • Imaging: While not routinely required, imaging studies such as endoscopy may be indicated in severe cases to assess mucosal involvement and rule out deeper tissue infections.
  • Serological Testing: Serological tests can be useful for detecting antibodies against specific viral pathogens, particularly in cases where acute infection is suspected but not confirmed by direct testing methods.
  • Histopathology: In cases where the diagnosis remains elusive, histopathological examination of biopsied tissue can provide definitive evidence of fungal invasion or other underlying pathologies.
  • The integration of these diagnostic tools, guided by clinical suspicion and patient-specific risk factors, is essential for accurate diagnosis and timely intervention.

    Management

    The management of vesicular pharyngitis depends significantly on the identified etiology, with tailored approaches for viral and fungal infections being paramount.

    Viral Infections

    For viral causes such as Coxsackievirus and Enterovirus, management primarily focuses on supportive care:

  • Symptomatic Relief: Analgesics for pain relief, antipyretics for fever management, and hydration support are crucial.
  • Infection Control: Measures to prevent transmission, such as hand hygiene and isolation if necessary, are essential, especially in institutional settings.
  • Monitoring: Close monitoring for complications such as dehydration, secondary bacterial infections, or neurological sequelae (in severe cases like those involving Enterovirus 71) is necessary.
  • Fungal Infections

    In cases where Candida or other fungal pathogens are identified, antifungal therapy becomes critical:

  • Antifungal Therapy: Systemic antifungal agents such as fluconazole or echinocandins may be required, particularly in severe or disseminated infections. The choice of antifungal should be guided by susceptibility testing results when available.
  • Local Treatment: Topical antifungals might be used for localized lesions to complement systemic therapy.
  • Immune Support: For immunocompromised patients, enhancing immune function through appropriate interventions (e.g., immunoglobulin therapy) may be considered alongside antifungal treatment.
  • General Considerations

  • Patient Monitoring: Regular follow-up is essential to monitor response to treatment and detect any potential complications early.
  • Education: Educating patients and caregivers about the importance of adherence to treatment and preventive measures against reinfection is crucial.
  • Key Recommendations

  • Broad Differential: Always consider a broad differential diagnosis, including fungal infections like Candida, especially in neonates and immunocompromised patients.
  • Comprehensive Testing: Utilize a combination of clinical samples, imaging, and serological testing to confirm the etiology accurately.
  • Tailored Treatment: Implement treatment strategies based on the identified pathogen, emphasizing supportive care for viral infections and targeted antifungal therapy for fungal causes.
  • Close Monitoring: Regularly monitor patients for response to treatment and potential complications, particularly in high-risk groups.
  • By adhering to these recommendations, clinicians can enhance the accuracy of diagnosis and optimize management strategies for patients presenting with vesicular pharyngitis, ensuring better outcomes and reducing the risk of complications.

    References

    1 Shope C, Cotton CH, Wine Lee L. Congenital erosive and vesicular dermatosis healing with reticulated and supple scarring: Two cases secondary to fungal infection. Pediatric dermatology 2023. link

    1 papers cited of 5 indexed.

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG